Toggle light / dark theme

The New Gold Standard: When AI Tokens Become the Currency of the Future

I’ve spent years watching finance and technology slowly adapt to one another, but the shift we’re looking at right now is going to change the entire landscape overnight. We need to stop thinking of AI as just a software tool or a cool shortcut for writing emails. We are officially entering an era where computational power is a foundational global commodity—and the standard unit of that commodity is the AI token.

Think of it like digital energy. Just as factories consume kilowatt-hours of electricity, modern enterprises now have to “burn” tokens to power their workflows. In my latest piece, I break down the massive hidden risk of letting a few Big Tech hyperscalers control both the production of this raw material and the infrastructure of exchange. This is where the banking sector has to step in, not just to cut their own costs, but to act as the ultimate market makers for artificial thought.

I dive deep into how banks will soon offer token futures markets—allowing companies to hedge their computing costs the exact same way airlines hedge aviation fuel—and how autonomous AI agents will soon be transacting with each other using tokenized value. The institutions that build these financial rails now will own the next century of commerce, while the rest risk being left behind in an aging system.

Click through to read the full breakdown on how the machine-to-machine economy is actually going to work!

(https://www.linkedin.com/pulse/new-gold-standard-when-ai-tok…Resilience over Political Influence: History shows that attempting to lobby a system to be “less exploitative” rarely works because the system is designed for extraction. True survival in this model might mean finding “off-grid” pockets where the resource demand is low enough to fly under the AI’s radar, or where the land is unsuitable for massive data centers.


I have spent a significant portion of my career watching the tectonic plates of finance and technology grind against each other. Usually, it is a slow, methodical process—a gradual shifting of legacy systems adapting to new digital realities. But every so often, a shift occurs that is so profound, it completely redefines the landscape overnight. We are standing on the precipice of one of those shifts right now.

Dr David Sinclair: What if Aging Isn’t Inevitable, But We Can Actually Slow It Down or Reverse It?

In this groundbreaking conversation, Professor of Genetics and longevity scientist, Dr. David Sinclair, A.O., Ph.D., joins Sarah Grynberg to unpack the future of human aging, the science of longevity, and how we live today impacts how we age tomorrow.

From reversing blindness in mice to exploring treatments that could one day delay menopause and extend healthy human life, this episode will completely change the way you think about your body, your health, and your future.

But beyond the science, this is also a deeply human conversation about purpose, suffering, love, family, and what it truly means to live a great life.

In this episode, you will learn:
Why aging may actually be reversible.
The daily habits accelerating aging in your body right now.
How stress, loneliness, and cortisol could impact longevity.
The real science behind supplements like NMN, resveratrol, and NAD boosters.
Why exercise, sleep, and relationships matter more than you think.
What Dr. Sinclair believes is coming in the next 10 years of medicine.
How scientists are working to reverse female infertility and delay menopause.
The surprising reason your “biological age” may be younger or older than your real age.
Why suffering through disease and decline should not be considered “normal aging”
The philosophy and mindset Dr. Sinclair lives by every day.

00:00 — Introduction.
01:18 — Why David Sinclair Became Obsessed With Aging.
06:20 — The Childhood Conversation That Changed His Life.
10:18 — The Groundbreaking Discovery That Could Reverse Aging.
12:47 — Reversing Blindness In Mice.
13:33 — Human Trials Are About To Begin.
16:11 — What Accelerates Aging Faster Than Anything Else.
20:08 — Why Relationships & Loneliness Impact Longevity.
24:14 — The Truth About Sun Exposure & Aging.
28:59 — Alzheimer’s, Cancer & Diseases Of Aging.
35:28 — Will Humans Live Longer In The Next Decade?
38:34 — The Supplements David Sinclair Personally Takes.
46:50 — Menopause, Fertility & Reversing Ovarian Aging.
50:20 — What Humans Will Eventually Die From.
51:18 — The Difference Between His Mother & Father’s Aging.
55:37 — Skin Rejuvenation, Hair Growth & Looking Younger.
58:16 — Why He Became A “Struggling Vegan”
01:00:08 — David Sinclair’s Workout & Exercise Routine.
01:03:28 — The Lifespan Community & Podcast.
01:06:02 — The Best Advice He’s Ever Received.
01:08:09 — What A Life Of Greatness Means To David Sinclair.

This episode is a powerful reminder that longevity is not just about living longer… it’s about living better.

Breakthrough drug reverses aging in skin and dramatically speeds healing

Scientists have discovered that a topical anti-aging drug called ABT-263 can dramatically improve wound healing in older skin. The treatment works by removing damaged “senescent” cells that accumulate with age and slow the body’s repair process. In aged mice, wounds healed much faster after treatment, while the drug also activated genes tied to collagen production and tissue regeneration.

A Common Blood Pressure Drug Boosts Lifespan And Slows Aging in Animals

The drug rilmenidine is usually taken to treat hypertension, but its powers appear to go far beyond that.

In fact, research shows rilmenidine can slow aging in worms – an effect that, if it translates to humans, could one day help us live longer and stay healthier in old age.

Rilmenidine appears to mimic the effects of caloric restriction on a cellular level, and reducing available energy while maintaining nutrition has been shown to extend lifespans in several animal models.

Senescent cells dodge cell death by rewiring fat metabolism, study shows

In response to stress or damage, cells undergo senescence and stop dividing. However, if senescent cells accumulate in tissues over the long term, chronic inflammation occurs and the risk of cancer increases. Researchers at the German Cancer Research Center (DKFZ) have now discovered a previously unknown mechanism by which senescent cells protect themselves from oxidative stress and a specific form of cell death known as ferroptosis.

In the long term, these findings could provide new avenues for cancer therapies and the treatment of age-related diseases. The research is published in the journal Cell Death & Differentiation.

Senescence occurs when cells respond to stress or harmful changes and permanently cease their growth. This process is considered a protective mechanism against cancer. For example, cells that carry an oncogene permanently activated by mutations are effectively “frozen” before they can proliferate uncontrollably—a biological emergency program. However, problems arise when senescent cells accumulate in tissue, where they promote chronic inflammation and thus facilitate tumor development. Scientists are therefore searching for ways to eliminate senescent cells before they can cause harm.

Neuroproteasomes regulate endogenous tau paired helical filament formation in an APOE genotype- and age-dependent manner

A cellular explanation for how tau aggregates into fibrils in Alzheimer’s disease has been elusive. This paper identifies the failure of ‘neuroproteasomes’ as sufficient to convert tau into paired helical filaments, a process regulated by ApoE and aging.

Zoltan Istvan: The Transhumanist Wager Is A Choice We’ll All Have To Make

Thirteen years ago, I sat down with a writer who had just published his first novel.

It was Zoltan Istvan’s very first media interview as a book author.

The book was The Transhumanist Wager. The question behind it was simple and almost unbearable: what would you do, and what would you give up, to live forever?

I loved half of it. I argued with the other half. That tension is exactly why I think it still matters.

Zoltan built his story out of Plato and Nietzsche, out of Thomas More’s Utopia and Zen Buddhism, then wrapped it all in an Atlas Shrugged plot of lone heroes and evil states. The philosophy is sophisticated. The framing is stark. The contradictions are not a flaw. They are the point.

One line from our conversation has stayed with me for more than a decade:

BREAKTHROUGH CHOLESTEROL CURE Lowers LDL For Life

New LDL Drug Could Cure Heart Disease. Eli Lilly published Phase 1 data in the New England Journal of Medicine showing that a single IV infusion of a gene editing therapy called VERVE-102 lowered LDL cholesterol permanently. Well… the effect held for at least 18 months. Longevity Twitter immediately called it the cure for heart disease. The science is real. The hype is getting ahead of what the paper actually says. This episode walks through the Phase 1 Heart-2 trial — the data, the base-editing mechanism (which is NOT CRISPR), the one safety event nobody’s talking about, and how Eli Lilly’s CEO is publicly thinking about pricing a one-and-done cure.

HUME BODY POD DISCOUNT UP TO 50% OFF:
Code: LSN20
https://humehealth.com/pages/hume-bod… Latte: https://longevitylatte.shop TIMESTAMPS 0:00 — Cold Open 1:41 — Sponsor: Hume Body Pod 2:53 — Intro: The Cholesterol Paradox 4:48 — How Statins Work 5:36 — PCSK9 Targeting 7:38 — How VERVE-102 Works 9:16 — The Results 12:16 — Other Drugs and Pricing 15:12 — Natural Alternatives 17:42 — Other One and Done Drugs 18:40 — Longevity Latte SOURCES & LINKS NEJM paper (Vafai, Täubel, Patel, Kathiresan et al.): https://www.nejm.org/doi/full/10.1056… Eli Lilly press release on Phase 1 Heart-2 data: https://www.prnewswire.com/news-relea… ClinicalTrials.gov Heart-2 trial entry (NCT06164730): https://clinicaltrials.gov/study/NCT0… Verve Therapeutics FDA Fast Track designation announcement: https://vervetx.gcs-web.com/news-rele… Cohen and Hobbs 2006 NEJM paper (the foundational PCSK9 loss-of-function discovery): https://www.nejm.org/doi/abs/10.1056/.… Dave Ricks (Eli Lilly CEO) on Cheeky Pint with Patrick and John Collison: • Dave Ricks, CEO of Eli Lilly, on GLP-1s an… FOURIER trial (evolocumab cardiovascular outcomes): https://www.nejm.org/doi/full/10.1056… ODYSSEY OUTCOMES trial (alirocumab cardiovascular outcomes): https://www.nejm.org/doi/full/10.1056… PCSK9 LoF and diabetes (Mendelian randomization, Lancet Diabetes & Endocrinology): https://www.thelancet.com/journals/la… PCSK9 inhibition and diabetes risk review: https://pmc.ncbi.nlm.nih.gov/articles… StatPearls overview of PCSK9 inhibitors: https://www.ncbi.nlm.nih.gov/books/NB… Sardinia cholesterol paradox study: https://pmc.ncbi.nlm.nih.gov/articles… Statin pleiotropic effects review (mevalonate pathway): https://www.ncbi.nlm.nih.gov/pmc/arti… Berberine as a nature-made PCSK9 inhibitor review: https://www.ncbi.nlm.nih.gov/pmc/arti… Berberine for dyslipidaemias meta-analysis: https://pubmed.ncbi.nlm.nih.gov/30466… Pomegranate juice, carotid IMT, and LDL oxidation (Aviram 3-year study): https://www.clinicalnutritionjournal… LATEST EXCLUSIVE INTERVIEW: [Ariel Garten / Muse headset interview YouTube URL] ABOUT LONGEVITY SCIENCE NEWS Longevity Science News covers the latest breakthroughs in anti-aging research, regenerative medicine, longevity biotech, and the science of extending human healthspan and lifespan. Hosted by Emmett Short. Disclaimer: This video is for educational and informational purposes only and does not constitute medical advice. Consult a qualified clinician before making health or treatment decisions. EXCLUSIVE INTERVIEWS & BONUS CONTENT Patreon: https://patreon.com/u29506604?utm_med… YT Membership: / @longevitysciencenews PRODUCTION CREDITS Executive Producer – Keith Comito Host, Producer, Writer – Emmett Short.

Longevity Latte:
https://longevitylatte.shop.

TIMESTAMPS
0:00 — Cold Open.
1:41 — Sponsor: Hume Body Pod.
2:53 — Intro: The Cholesterol Paradox.
4:48 — How Statins Work.
5:36 — PCSK9 Targeting.
7:38 — How VERVE-102 Works.
9:16 — The Results.
12:16 — Other Drugs and Pricing.
15:12 — Natural Alternatives.
17:42 — Other One and Done Drugs.
18:40 — Longevity Latte.

SOURCES \& LINKS
NEJM paper (Vafai, Täubel, Patel, Kathiresan et al.): https://www.nejm.org/doi/full/10.1056
Eli Lilly press release on Phase 1 Heart-2 data: https://www.prnewswire.com/news-relea
ClinicalTrials.gov Heart-2 trial entry (NCT06164730): https://clinicaltrials.gov/study/NCT0
Verve Therapeutics FDA Fast Track designation announcement: https://vervetx.gcs-web.com/news-rele
Cohen and Hobbs 2006 NEJM paper (the foundational PCSK9 loss-of-function discovery): https://www.nejm.org/doi/abs/10.1056/.
Dave Ricks (Eli Lilly CEO) on Cheeky Pint with Patrick and John Collison: • Dave Ricks, CEO of Eli Lilly, on GLP-1s an…

Jacque Fresco: Apply the Methods of Science to the Social System!

I have to confess something about this interview.

I really liked Jacque Fresco. Not as a thinker I was supposed to admire, but as a person: the humor, the humility, the scientific curiosity still burning at 97.

That made the disagreements harder, not easier.

Fresco spent almost a century arguing one idea. We apply the methods of #science to engineering, to medicine, to flight. Then we run our economies and our politics on opinion, tradition, and the preferences of the financial elite.

He thought we had it exactly inverted. Rigor for the machines, guesswork for the humans.

“Technology was never the hard part. The harder question is what kind of society we want it to serve.”

A retention-aware system turns a computer’s storage chip into a cybersecurity shield

Hackers are ruthless. They can take control of your computer, delete files and disappear without a trace. However, FIU cybersecurity researcher Weidong Zhu has discovered a way to transform a computer’s storage chip into an additional tool for cyber defense. Working with collaborators at the University of Florida, Zhu created a system that makes data on these chips last longer—extending the lifespan of your files in the critical window after your computer is compromised. The work is published in the journal Proceedings of the 2025 ACM SIGSAC Conference on Computer and Communications Security.

“Our system extends recoverable data history up to 126 days,” said Zhu, an assistant professor at FIU’s Knight Foundation School of Computing & Information Sciences whose work is part of the Center for Integrated Security, Privacy, and Trustworthy AI (CIERTA). “Even if your computer is infected, your data can survive on your drive.”

Storage chips, known as solid-state drives (SSDs), have intrigued cybersecurity researchers for years. As hardware—not software—they offer unique safety benefits during an attack.

/* */